Key result
Hospitalist utilization was not significantly associated with differences in publicly reported mortality or readmission measures for AMI, HF, or pneumonia, except for risk-stratified HF readmission.
Why the study?
Does hospitalist utilization improve performance on publicly reported mortality and readmissions measures for AMI, HF, and pneumonia in US hospitals?
Cross-Sectional (n=598)
Yes
Does hospitalist utilization improve performance on publicly reported mortality and readmissions measures for AMI, HF, and pneumonia in US hospitals?
The presence of hospitalists is not an independent predictor of performance on publicly reported mortality and readmissions measures for AMI, HF, or pneumonia.
Hospitalist utilization shows no broad link to mortality or readmission metrics; hypothesis-generating for HF readmissions and requires prospective study.
BACKGROUND: The increase in hospitalist-provided inpatient care may be accompanied by an expectation of improvement on patient outcomes. To date, the association between utilization of hospitalists and the publicly reported patient outcomes is unknown. OBJECTIVE: Assess the relationship between hospitalist utilization and performance on 6 publicly reported patient outcomes. DESIGN: Cross-sectional study. PARTICIPANTS: Representatives of 598 hospitals in the United States with direct knowledge of inpatient service models. INTERVENTION: Survey of hospital personnel with knowledge of hospitalist use and hospitalist programs. MEASUREMENTS: Six publicly reported quality outcome measures across 3 medical conditions: acute myocardial infarction (AMI), congestive heart failure (HF), and pneumonia. Using multivariable regression models, we assessed the relationship between presence of hospitalists and performance on each outcome measure; we further assessed the relationship between the percentage of patients admitted by hospitalists and each outcome measure. RESULTS: Of 598 respondents, 429 (72%) reported the use of hospitalist services. In the comparison of hospitals with and without hospitalists, there was no statistically significant difference on any of the mortality or readmissions measures with the exception of the risk-stratified readmission rate for heart failure. For hospitals that used hospitalists, there was no significant change in any of the outcome measures with increasing percentage of patients admitted by hospitalists. CONCLUSIONS: The presence of hospitalists is not an independent predictor of performance on publicly reported mortality and readmissions measures for AMI, HF, or pneumonia. It is likely that broader system or organizational interventions are required to improve performance on patient outcomes.
No takes yet. Share an insight, caveat, or question.
Goodrich et al. (2012) conducted a cross-sectional in Acute myocardial infarction, congestive heart failure, and pneumonia (n=598). Hospitalist utilization vs. No hospitalist utilization was evaluated on Performance on 6 publicly reported mortality and readmissions measures for AMI, HF, and pneumonia. Hospitalist utilization was not significantly associated with differences in publicly reported mortality or readmission measures for AMI, HF, or pneumonia, except for risk-stratified HF readmission.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: